|
|||||
|
|
Cost‐effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment‐naïve adults with HIV‐1 infection in the UK,based on the AIDS Clinical Trials Group 5202 clinical trial |
|
| Authors: | E Wilkins AJ Brogan SE Talbird EM La |
| Affiliation: | 1. North Manchester General Hospital, Manchester, UK;2. RTI Health Solutions, Research Triangle Park, NC, USA |
| Abstract: | |
| Keywords: | abacavir/lamivudine ACTG 5202 clinical trial cost‐effectiveness analysis HIV tenofovir/emtricitabine |